Tapewire

NYSE · USD

CVS

CVS HEALTH Corp

Export transactions ↓
Tapewire entity
2884
SEC CIK
0000064803
Parsed reports
1,748

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 12, 2010 Filed May 14, 2010 20:07 UTC GrantShare Credits · Derivative 3,579.2952 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014349 · form4.xml · derivative · entry 1

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,732.6388

Underlying: Common Stock · 3,579.2952 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:05 UTC GrantCommon Stock 3,854 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014348 · form4.xml · nonDerivative · entry 1

MURRAY TERRENCE · CIK 0001196361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,477

F1 · shares: Consists of common stock acquired as semi-annual compensation.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:09 UTC GrantShare Credits · Derivative 2,684.4714 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014353 · form4.xml · derivative · entry 1

HEARD MARIAN L · CIK 0001198220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,719.9759

Underlying: Common Stock · 2,684.4714 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:11 UTC GrantShare Credits · Derivative 3,854.6256 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014356 · form4.xml · derivative · entry 1

JOYCE WILLIAM H · CIK 0001009124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,495.4564

Underlying: Common Stock · 3,854.6256 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:12 UTC GrantShare Credits · Derivative 3,579.2952 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014357 · form4.xml · derivative · entry 1

SWIFT RICHARD J · CIK 0001200537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,062.4688

Underlying: Common Stock · 3,579.2952 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:14 UTC GrantCommon Stock 3,716 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014358 · form4.xml · nonDerivative · entry 1

DORMAN DAVID W · CIK 0001082870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,323

F1 · shares: Consists of common stock acquired as semi-annual compensation.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:17 UTC GrantCommon Stock 2,684 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014360 · form4.xml · nonDerivative · entry 1

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,684

F1 · shares: Consists of common stock acquired as semi-annual compensation.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:18 UTC
PICCOLO C ADirector
GrantCommon Stock 2,684 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014361 · form4.xml · nonDerivative · entry 1

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,822

F1 · shares: Consists of common stock acquired as semi-annual compensation.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:15 UTC GrantCommon Stock 2,684 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014359 · form4.xml · nonDerivative · entry 1

WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,092

F1 · shares: Consists of common stock acquired as semi-annual compensation.

Read SEC document
May 12, 2010 Filed May 14, 2010 20:19 UTC GrantCommon Stock 3,716 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-014362 · form4.xml · nonDerivative · entry 1

ROSENBERG SHELI Z · CIK 0001198222 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,828.4607

F1 · shares: Consists of common stock acquired as semi-annual compensation.

Read SEC document
April 26, 2010 Filed Oct 7, 2011 20:34 UTC Amendment PurchaseCommon Stock 170 $36.67 $6,233.90
Disclosure

SEC source: 0001127602-11-027091 · form4a.xml · nonDerivative · entry 1

MURRAY TERRENCE · CIK 0001196361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,506

F1 · kind: The reporting person has disgorged to the issuer all short swing profits realized on the transactions reported on this Form 4, as amended hereby. The transactions were conducted in discretionary brokerage accounts without the reporting person's knowledge.

Read SEC document
April 03, 2010 Filed Apr 5, 2010 22:17 UTC Tax withholdingCommon Stock 349 $36.23 $12,644.27
Disclosure

SEC source: 0001127602-10-010571 · form4.xml · nonDerivative · entry 3

Denton David M · CIK 0001428718 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,860.0814

F2 · shares: Surrender of shares in payment of withholding taxes due.

Read SEC document
April 02, 2010 Filed Apr 5, 2010 22:03 UTC
RYAN THOMAS MDirector · CEO & President
Tax withholdingCommon Stock 25,248 $36.23 $914,735.04
Disclosure

SEC source: 0001127602-10-010563 · form4.xml · nonDerivative · entry 2

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 821,345.8778

F2 · shares: Surrender of shares in payment of withholding taxes due.

Read SEC document
April 02, 2010 Filed Apr 5, 2010 22:10 UTC
SGARRO DOUGLAS AExecutive Vice President
Tax withholdingCommon Stock 2,841 $36.23 $102,929.43
Disclosure

SEC source: 0001127602-10-010565 · form4.xml · nonDerivative · entry 2

SGARRO DOUGLAS A · CIK 0001194417 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,047.6044

F2 · shares: Surrender of shares in payment of withholding taxes due.

F3 · ownership.direct: Includes dividend reinvestment shares acquired during the course of the year.

Read SEC document
April 02, 2010 Filed Apr 5, 2010 22:17 UTC Tax withholdingCommon Stock 2,916 $36.23 $105,646.68
Disclosure

SEC source: 0001127602-10-010571 · form4.xml · nonDerivative · entry 2

Denton David M · CIK 0001428718 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,209.0814

F2 · shares: Surrender of shares in payment of withholding taxes due.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:06 UTC
MERLO LARRY JExecutive Vice President
GrantStock Option · Derivative 152,988 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010564 · form4.xml · derivative · entry 6

MERLO LARRY J · CIK 0001194413 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,988

Underlying: Common Stock · 152,988 shares

Expires 2017-04-01

F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:06 UTC
MERLO LARRY JExecutive Vice President
GrantCommon Stock (restricted) 41,403 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010564 · form4.xml · nonDerivative · entry 1

MERLO LARRY J · CIK 0001194413 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,834

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:03 UTC
RYAN THOMAS MDirector · CEO & President
GrantStock Option · Derivative 446,215 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010563 · form4.xml · derivative · entry 7

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 446,215

Underlying: Common Stock · 446,215 shares

Expires 2017-04-01

F3 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:03 UTC
RYAN THOMAS MDirector · CEO & President
GrantCommon Stock (restricted) 120,757 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010563 · form4.xml · nonDerivative · entry 1

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 672,828.4102

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:10 UTC
SGARRO DOUGLAS AExecutive Vice President
GrantStock Option · Derivative 133,865 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010565 · form4.xml · derivative · entry 5

SGARRO DOUGLAS A · CIK 0001194417 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,865

Underlying: Common Stock · 133,865 shares

Expires 2017-04-01

F4 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:10 UTC
SGARRO DOUGLAS AExecutive Vice President
GrantCommon Stock (restricted) 12,076 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010565 · form4.xml · nonDerivative · entry 1

SGARRO DOUGLAS A · CIK 0001194417 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,969

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:14 UTC
Brennan Troyen AChief Medical Officer
GrantStock Option · Derivative 103,267 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010568 · form4.xml · derivative · entry 4

Brennan Troyen A · CIK 0001351402 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,267

Underlying: Common Stock · 103,267 shares

Expires 2017-04-01

F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:14 UTC
Brennan Troyen AChief Medical Officer
GrantCommon Stock (restricted) 9,316 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010568 · form4.xml · nonDerivative · entry 1

Brennan Troyen A · CIK 0001351402 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,059

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:17 UTC GrantStock Option · Derivative 95,618 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010571 · form4.xml · derivative · entry 6

Denton David M · CIK 0001428718 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,618

Underlying: Common Stock · 95,618 shares

Expires 2017-04-01

F3 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:17 UTC GrantCommon Stock (restricted) 8,626 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010571 · form4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,502.2856

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 7/23/2020.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:22 UTC
Foulkes HelenaSenior Vice President
GrantStock Option · Derivative 53,546 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010573 · form4.xml · derivative · entry 5

Foulkes Helena · CIK 0001429996 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,546

Underlying: Common Stock · 53,546 shares

Expires 2017-04-01

F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:22 UTC
Foulkes HelenaSenior Vice President
GrantCommon Stock (restricted) 4,831 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010573 · form4.xml · nonDerivative · entry 1

Foulkes Helena · CIK 0001429996 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,616

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 7/22/2019.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:19 UTC
Roberts Jonathan CExecutive Vice President
GrantStock Option · Derivative 61,196 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010572 · form4.xml · derivative · entry 5

Roberts Jonathan C · CIK 0001410515 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,196

Underlying: Common Stock · 61,196 shares

Expires 2017-04-01

F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:19 UTC
Roberts Jonathan CExecutive Vice President
GrantCommon Stock (restricted) 5,521 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010572 · form4.xml · nonDerivative · entry 1

Roberts Jonathan C · CIK 0001410515 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,244

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:28 UTC GrantStock Option · Derivative 53,546 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010574 · form4.xml · derivative · entry 4

MCGUIGAN STUART M · CIK 0001335234 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,546

Underlying: Common Stock · 53,546 shares

Expires 2017-04-01

F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:28 UTC GrantCommon Stock (restricted) 4,831 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010574 · form4.xml · nonDerivative · entry 1

MCGUIGAN STUART M · CIK 0001335234 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,170

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:35 UTC
Bisaccia LisaSVP, Chief HR Officer
GrantStock Option · Derivative 45,897 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010576 · form4.xml · derivative · entry 3

Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,897

Underlying: Common Stock · 45,897 shares

Expires 2017-04-01

F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:35 UTC
Bisaccia LisaSVP, Chief HR Officer
GrantCommon Stock (restricted) 4,141 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010576 · form4.xml · nonDerivative · entry 1

Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,544.7226

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:41 UTC
Finley SaraSVP, Gen Counsel
GrantStock Option · Derivative 27,610 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010579 · form4.xml · derivative · entry 5

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,610

Underlying: Common Stock · 27,610 shares

Expires 2020-04-01

F4 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2013.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:41 UTC
Finley SaraSVP, Gen Counsel
GrantStock Option · Derivative 49,722 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010579 · form4.xml · derivative · entry 4

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,722

Underlying: Common Stock · 49,722 shares

Expires 2017-04-01

F3 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:41 UTC
Finley SaraSVP, Gen Counsel
GrantCommon Stock (pep) 2,761 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010579 · form4.xml · nonDerivative · entry 2

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,761

F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's Partnerhship Equity Program under the 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2015.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:41 UTC
Finley SaraSVP, Gen Counsel
GrantCommon Stock (restricted) 4,486 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010579 · form4.xml · nonDerivative · entry 1

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,799

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 4/1/2014.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:49 UTC
Lofberg Per GHPresident, Caremark Pharm Serv
GrantStock Option · Derivative 101,992 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-010580 · form4.xml · derivative · entry 5

Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,992

Underlying: Common Stock · 101,992 shares

Expires 2017-04-01

F2 · shares: Option become exercisable in three equal annual installments commencing 4/1/2011 and the third installment becomes excisable on 12/31/2012.

Read SEC document
April 01, 2010 Filed Apr 5, 2010 22:49 UTC
Lofberg Per GHPresident, Caremark Pharm Serv
GrantCommon Stock (restricted) 27,602 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-010580 · form4.xml · nonDerivative · entry 1

Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,602

F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 12/31/2012 and 50% on 4/1/2013.

Read SEC document
April 01, 2010 Filed Aug 10, 2010 16:59 UTC Amendment
Lofberg Per GHPresident, Caremark Pharm Serv
GrantStock Option · Derivative 101,992 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-021023 · form4a.xml · derivative · entry 2

Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,992

Underlying: Common Stock · 101,992 shares

Expires 2017-04-01

F2 · derivative.exercise_date: The Option become exercisable in three equal installments on April 1, 2011, April 1, 2012 and April 1, 2013, provided, however, that if the reporting person remains employed through December 31, 2012, then the option shall become exercisable in full as of December 31, 2012, and shall remain exercisable for one year following the reporting person's last date of employment with the Company.

Read SEC document
April 01, 2010 Filed Aug 10, 2010 16:59 UTC Amendment
Lofberg Per GHPresident, Caremark Pharm Serv
GrantCommon Stock (restricted) 27,602 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-021023 · form4a.xml · nonDerivative · entry 1

Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,602

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on the third anniversary of the grant date, provided that if the reporting person remains employed by the Company through December 31, 2012, the restrictions lapse on December 31, 2012.

Read SEC document
April 01, 2010 Filed Sep 23, 2010 21:03 UTC
Daniels LairdSVP, Cont & Chief Acct Officer
GrantStock Option · Derivative 34,423 $0.00 Strike: $36.23 $0.00
Disclosure

SEC source: 0001127602-10-023732 · form4.xml · derivative · entry 4

Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,423

Underlying: Common Stock · 34,423 shares

Expires 2017-04-01

F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

Read SEC document
April 01, 2010 Filed Sep 23, 2010 21:03 UTC
Daniels LairdSVP, Cont & Chief Acct Officer
GrantCommon Stock (restricted) 3,106 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-023732 · form4.xml · nonDerivative · entry 1

Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,878

F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 4/1/2014.

Read SEC document
April 01, 2010 Filed Nov 2, 2010 14:52 UTC Amendment
Foulkes HelenaSenior Vice President
GrantCommon Stock (restricted) 4,831 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-026405 · form4a.xml · nonDerivative · entry 1

Foulkes Helena · CIK 0001429996 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,616

F1 · shares: The purpose of this Form 4/A is to correct a typographical error in the vesting schedule of this restricted stock award. Restrictions lapse in two equal installments, 50% on 4/1/2013 and 50% on 7/18/2019 (rather than 7/22/2019).

Read SEC document
March 22, 2010 Filed Mar 24, 2010 20:11 UTC
Finley SaraSVP, Gen Counsel
Tax withholdingCommon Stock 11,182 $35.19 $393,494.58
Disclosure

SEC source: 0001127602-10-009436 · form4.xml · nonDerivative · entry 1

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,386

F1 · shares: Surrender of shares in payment of withholding taxes due.

Read SEC document
March 17, 2010 Filed Mar 18, 2010 20:01 UTC
Foulkes HelenaSenior Vice President
SaleCommon Stock 7,000 $34.93 $244,510.00
Disclosure

SEC source: 0001127602-10-009066 · form4.xml · nonDerivative · entry 1

Foulkes Helena · CIK 0001429996 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 863.2352

Read SEC document
March 02, 2010 Filed Mar 3, 2010 21:16 UTC
Finley SaraSVP, Gen Counsel
Exercise / conversionStock Option · Derivative 183,165 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0001127602-10-007177 · form4.xml · derivative · entry 4

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 183,165 shares

Expires 2015-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of merger.

Read SEC document
March 02, 2010 Filed Mar 3, 2010 21:16 UTC
Finley SaraSVP, Gen Counsel
SaleCommon Stock 183,165 $34.51 $6,320,438.02
Disclosure

SEC source: 0001127602-10-007177 · form4.xml · nonDerivative · entry 2

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,525

F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $34.50 and $34.58 per share.

Read SEC document
March 02, 2010 Filed Mar 3, 2010 21:16 UTC
Finley SaraSVP, Gen Counsel
Exercise / conversionCommon Stock 183,165 $20.23 $3,705,427.95
Disclosure

SEC source: 0001127602-10-007177 · form4.xml · nonDerivative · entry 1

Finley Sara · CIK 0001481562 · SVP, Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2010 Filed Feb 19, 2010 20:43 UTC
Foulkes HelenaSenior Vice President
Tax withholdingCommon Stock 543 $0.00 $0.00
Disclosure

SEC source: 0001127602-10-005610 · form4.xml · nonDerivative · entry 2

Foulkes Helena · CIK 0001429996 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,863.2352

F1 · shares: Surrender of shares in payment of withholding taxes due.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.